title: Sexually dimorphic alterations in locomotion and reversal learning after adolescent tetrahydrocannabinol exposure in the rat.
abstract: Research suggests that use and abuse of marijuana can be especially harmful if it occurs during adolescence, a period of vast developmental changes throughout the brain. We examined the effects of 2mg/kg (9)-tetrahydrocannabinol (THC) administered daily via intra-peritoneal injections during juvenile/early adolescence (postnatal day 22-40) or late adolescence (postnatal day 41-60) on locomotor activity, development of tolerance, and acquisition/retention of spatial avoidance in adulthood. THC caused locomotor depression in both male and female animals dosed during early adolescence but only in female animals dosed during late adolescence. Evidence of reverse tolerance to THC was seen in early adolescent animals only. In the active place avoidance test (APA), male and female animals administered THC during early adolescence made more errors on the reversal trial requiring flexibility in learning, but in animals dosed during late adolescence there were no significant sex or treatment differences. The results of the locomotor activity study indicate that females may be more sensitive to the effects of THC than males, while results of both locomotor activity and APA studies suggest that early adolescents appear to be more vulnerable to these effects than late adolescents/young adults.
authors.affiliation: Department of Physiology/Pharmacology, Program in Neural and Behavioral Sciences, State University of New York Downstate Medical Center, 450 Clarkson Avenue, Brooklyn, NY 11203, USA.
authors.forename: Lauren C
authors.initials: LC
authors.lastname: Harte
authors.forename: Diana
authors.initials: D
authors.lastname: Dow-Edwards
mesh_terms: D000367:Age Factors; D000818:Animals; D000831:Animals, Newborn; D001362:Avoidance Learning / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects; D013759:Dronabinol / Q000494:pharmacology*; D005260:Female; D006213:Hallucinogens / Q000494:pharmacology*; D008124:Locomotion / Q000187:drug effects*; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D012153:Retention, Psychology / Q000187:drug effects; D012193:Reversal Learning / Q000187:drug effects*; D012727:Sex Characteristics; D018709:Statistics, Nonparametric
chemical_list: D006213:Hallucinogens; D013759:Dronabinol
references.citation: Neurotoxicol Teratol. 1995 Jan-Feb;17(1):25-30
references.pmid: 7708016
references.citation: J Cogn Neurosci. 2004 Sep;16(7):1227-33
references.pmid: 15453975
references.citation: Neuropsychopharmacology. 2008 Oct;33(11):2760-71
references.pmid: 18172430
references.citation: Crit Rev Neurobiol. 2003;15(2):91-119
references.pmid: 14977366
references.citation: J Neurochem. 1999 Dec;73(6):2447-59
references.pmid: 10582605
references.citation: Neurosci Biobehav Rev. 2002 Oct;26(6):631-64
references.pmid: 12479840
references.citation: Synapse. 1998 Nov;30(3):298-308
references.pmid: 9776133
references.citation: J Neurosci. 1991 Feb;11(2):563-83
references.pmid: 1992016
references.citation: Prog Neurobiol. 1999 Jul;58(4):315-48
references.pmid: 10368032
references.citation: Drug Alcohol Depend. 2003 Aug 20;71(2):169-77
references.pmid: 12927655
references.citation: Annu Rev Neurosci. 2007;30:123-52
references.pmid: 17417939
references.citation: Neuroscientist. 2004 Aug;10(4):372-92
references.pmid: 15271264
references.citation: Neuropsychopharmacology. 2003 Jul;28(7):1356-65
references.pmid: 12784123
references.citation: Br J Pharmacol. 2007 Jul;151(5):688-700
references.pmid: 17502849
references.citation: Drug Alcohol Depend. 2009 Aug 1;103(3):107-13
references.pmid: 19443132
references.citation: Neurosci Biobehav Rev. 2000 Jun;24(4):417-63
references.pmid: 10817843
references.citation: Neuropsychopharmacology. 2006 Feb;31(2):462-70
references.pmid: 16177808
references.citation: Eur Neuropsychopharmacol. 2008 Nov;18(11):826-34
references.pmid: 18674887
references.citation: Behav Neurosci. 2001 Jun;115(3):695-703
references.pmid: 11439458
references.citation: Proc Natl Acad Sci U S A. 1990 Mar;87(5):1932-6
references.pmid: 2308954
references.citation: J Pharmacol Exp Ther. 2007 Mar;320(3):1097-105
references.pmid: 17172531
references.citation: Pharmacol Biochem Behav. 1993 Nov;46(3):575-9
references.pmid: 8278434
references.citation: Pharmacol Biochem Behav. 2008 Jan;88(3):230-7
references.pmid: 17888506
references.citation: J Clin Pharmacol. 1981 Aug-Sep;21(S1):208S-214S
references.pmid: 6271826
references.citation: Neuroreport. 1993 Feb;4(2):135-8
references.pmid: 8453049
references.citation: Psychopharmacology (Berl). 2002 May;161(2):129-36
references.pmid: 11981592
references.citation: Trends Neurosci. 2005 Jul;28(7):364-70
references.pmid: 15935487
references.citation: J Neurosci. 2005 Mar 2;25(9):2413-9
references.pmid: 15745968
references.citation: Psychopharmacology (Berl). 2008 Jan;196(1):119-31
references.pmid: 17899017
references.citation: Neurosci Lett. 2008 Jul 4;439(1):89-93
references.pmid: 18513870
references.citation: Eur J Neurosci. 2001 Sep;14(5):884-6
references.pmid: 11576193
references.citation: Psychopharmacology (Berl). 2007 May;191(4):867-77
references.pmid: 17211649
references.citation: Biochem Pharmacol. 1991 Apr 15;41(8):1187-94
references.pmid: 1848985
references.citation: Behav Brain Res. 2004 Sep 23;154(1):77-83
references.pmid: 15302113
references.citation: J Pharmacol Exp Ther. 2002 Jun;301(3):915-24
references.pmid: 12023519
references.citation: Brain Res. 1993 Jul 9;616(1-2):293-302
references.pmid: 8395305
references.citation: Eur J Pharmacol. 2008 May 13;585(2-3):458-63
references.pmid: 18423599
references.citation: J Neurochem. 2008 Aug;106(4):1586-93
references.pmid: 18513369
references.citation: Cereb Cortex. 2006 Apr;16(4):553-60
references.pmid: 16033925
references.citation: Brain. 2003 Jun;126(Pt 6):1252-70
references.pmid: 12764049
references.citation: Life Sci. 1994;54(3):159-70
references.pmid: 8289577
references.citation: Eur J Pharmacol. 2008 Jan 6;578(1):37-42
references.pmid: 17905227
references.citation: Neuropsychopharmacology. 2008 Apr;33(5):1113-26
references.pmid: 17581536
references.citation: Dev Rev. 2008;28(1):62-77
references.pmid: 18688292
references.citation: Drug Alcohol Depend. 2000 Aug 1;60(2):113-9
references.pmid: 10940538
references.citation: Psychopharmacology (Berl). 2008 Dec;201(2):171-81
references.pmid: 18695931
references.citation: Synapse. 2005 Jan;55(1):1-16
references.pmid: 15499609
references.citation: Drug Alcohol Depend. 2003 Apr 1;69(3):303-10
references.pmid: 12633916
references.citation: Neuropsychopharmacology. 2005 Oct;30(10):1895-905
references.pmid: 15812570
references.citation: NIDA Res Monogr. 1997;167:59-80
references.pmid: 9243557
references.citation: Neurobiol Learn Mem. 2008 Sep;90(2):374-81
references.pmid: 18524639
references.citation: Jpn J Pharmacol. 2001 Dec;87(4):297-308
references.pmid: 11829149
references.citation: Pharmacol Biochem Behav. 2006 Mar;83(3):448-55
references.pmid: 16631921